← Back to patent-cliff list
CAS 216437-33-1
2-(hexadecyloxy)-1,3,2-dioxaphospholane
Codes: Miltefosine-012
Application context (from source-drug indications)
利什曼原虫感染Miltefosine皮肤利什曼病MiltefosineChronic urticariaMiltefosine内脏利什曼病Miltefosine粘膜皮肤利什曼病Miltefosine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Miltefosine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-Hexadecanol→2-Chloro-1,3,2-dioxaphospholane→2-(hexadecyloxy)-1,3,2-dioxaphospholane→(2-bromoethyl) hexadecyl bromophosphonate→Dimethylamino methane
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.